# FDA 483 - Cure Pharmaceutical, Inc. - February 21, 2024

Source: https://www.keypedia.com/records/483/cure-pharmaceutical-inc/e3b0270b-4479-4db3-95eb-8cbc57a5b078

> FDA 483 for Cure Pharmaceutical, Inc. on February 21, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cure Pharmaceutical, Inc.
- Inspection Date: 2024-02-21
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Cure Pharmaceutical, Inc. in Oxnard, CA was inspected by the FDA from February 20-21, 2024. The inspection revealed two significant issues related to quality control for dietary supplement manufacturing. Specifically, the firm failed to ensure components met established specifications and did not adequately qualify suppliers by confirming their certificates of analysis.

## Related Officers

- [investigator](https://www.keypedia.com/people/greg-k-keshishyan/72308798-27be-4688-ba3c-63cd84fb1677)

Company: https://www.keypedia.com/companies/cure-pharmaceutical-inc/7add060f-9b4d-4450-b825-08f0036aa4f9

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6